Evidence map›Paper›PMID 33113606›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Clinical study of anti-human T cell porcine immunoglobulin with recombinant human tumor necrosis factor-α receptor II: IgG Fc in the treatment of 35 cases of grade III/IV acute graft-versus-host disease after allo-HSCT].

D Y Liu, S Yan, D D Ma, C Zhang, K B Fu, X M Liu, X H Liu, Y Wang, X Q Li, J Q Zhang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

D Y LiuDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
S YanDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
D D MaDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
C ZhangDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
K B FuDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
X M LiuDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
X H LiuDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Y WangDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
X Q LiDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
J Q ZhangDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Y Y XiuDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
X J PengDepartment of Hematopoietic Stem Cell Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China.
Luye Pharma (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAdolescentAdultAnimalsChildFemaleHumansImmunoglobulin GMaleMiddle AgedNeoplasm StagingReceptors, Tumor Necrosis Factor, Type IIRetrospective StudiesSwineT-LymphocytesImmunoglobulin GReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor-alphaAnti-human T cell porcine immunoglobulinGraft versus host diseaseRecombinant human tumor necrosis factor-α receptorⅡ: IgG Fc

Identifiers

PMID33113606
PMCPMC7595858
OpenAlexW3095179801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.